Clinical Trial Update: DMT310-009 Topical in the Treatment of Acne Vulgaris [Phase 3]

View source ↗

Summary

The Phase 3 trial of DMT310-009 topical for acne vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• DMT310-009

Snippet

Sponsor: Dermata Therapeutics | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED